Grazia Graziani
Grazia Graziani
Verified email at
TitleCited byYear
HP Rang, MM Dale, JM Ritter, RJ Flower
Elsevier, 2008
Involvement of the mismatch repair system in temozolomide-induced apoptosis
S D’Atri, L Tentori, PM Lacal, G Graziani, E Pagani, E Benincasa, ...
Molecular pharmacology 54 (2), 334-341, 1998
A region of proto-dbl essential for its transforming activity shows sequence similarity to a yeast cell cycle gene, CDC24, and the human breakpoint cluster gene, bcr.
D Ron, M Zannini, M Lewis, RB Wickner, LT Hunt, G Graziani, SR Tronick, ...
The New biologist 3 (4), 372-379, 1991
Systemic administration of GPI 15427, a novel poly (ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma …
L Tentori, C Leonetti, M Scarsella, G d’Amati, M Vergati, I Portarena, W Xu, ...
Clinical Cancer Research 9 (14), 5370-5379, 2003
Chemopotentiation by PARP inhibitors in cancer therapy
L Tentori, G Graziani
Pharmacological research 52 (1), 25-33, 2005
Potential clinical applications of poly (ADP-ribose) polymerase (PARP) inhibitors
L Tentori, I Portarena, G Graziani
Pharmacological research 45 (2), 73-85, 2002
Clinical perspectives of PARP inhibitors
G Graziani, C Szabó
Pharmacological research 52 (1), 109-118, 2005
Poly (ADP-ribose) polymerase (PARP) inhibition or PARP-1 gene deletion reduces angiogenesis
L Tentori, PM Lacal, A Muzi, AS Dorio, C Leonetti, M Scarsella, F Ruffini, ...
European Journal of Cancer 43 (14), 2124-2133, 2007
Alternative splicing generates at least five different isoforms of the human basic-FGF receptor.
A Eisemann, JA Ahn, G Graziani, SR Tronick, D Ron
Oncogene 6 (7), 1195-1202, 1991
Role of beauty treatment in the spread of parenterally transmitted hepatitis viruses in Italy
A Mariano, A Mele, ME Tosti, A Parlato, G Gallo, P Ragni, C Zotti, ...
Journal of medical virology 74 (2), 216-220, 2004
Ipilimumab: a novel immunostimulatory monoclonal antibody for the treatment of cancer
G Graziani, L Tentori, P Navarra
Pharmacological research 65 (1), 9-22, 2012
Inhibition of poly (ADP-ribose) polymerase prevents irinotecan-induced intestinal damage and enhances irinotecan/temozolomide efficacy against colon carcinoma
L Tentori, C Leonetti, M Scarsella, A Muzi, E Mazzon, M Vergati, O Forini, ...
The FASEB journal 20 (10), 1709-1711, 2006
Decline in telomerase activity as a measure of tumor cell killing by antineoplastic agents in vitro.
I Faraoni, M Turriziani, G Masci, L De Vecchis, JW Shay, E Bonmassar, ...
Clinical cancer research 3 (4), 579-585, 1997
Combined treatment with temozolomide and poly (ADP-ribose) polymerase inhibitor enhances survival of mice bearing hematologic malignancy at the central nervous system site
L Tentori, C Leonetti, M Scarsella, G d'Amati, I Portarena, G Zupi, ...
Blood 99 (6), 2241-2244, 2002
Doping with growth hormone/IGF-1, anabolic steroids or erythropoietin: is there a cancer risk?
L Tentori, G Graziani
Pharmacological research 55 (5), 359-369, 2007
Recent approaches to improve the antitumor efficacy of temozolomide
L Tentori, G Graziani
Current medicinal chemistry 16 (2), 245-257, 2009
PARP1 is activated at telomeres upon G4 stabilization: possible target for telomere-based therapy
E Salvati, M Scarsella, M Porru, A Rizzo, S Iachettini, L Tentori, G Graziani, ...
Oncogene 29 (47), 6280, 2010
Challenging resistance mechanisms to therapies for metastatic melanoma
L Tentori, PM Lacal, G Graziani
Trends in pharmacological sciences 34 (12), 656-666, 2013
Poly(ADP‐ribose) polymerase inhibitor increases growth inhibition and reduces G2/M cell accumulation induced by temozolomide in malignant glioma cells
L Tentori, I Portarena, F Torino, M Scerrati, P Navarra, G Graziani
Glia 40 (1), 44-54, 2002
CRH inhibits cell growth of human endometrial adenocarcinoma cells via CRH-receptor 1-mediated activation of cAMP-PKA pathway
G Graziani, L Tentori, I Portarena, M Barbarino, G Tringali, G Pozzoli, ...
Endocrinology 143 (3), 807-813, 2002
The system can't perform the operation now. Try again later.
Articles 1–20